AbCellera Biologics, Inc. (ABCL) is currently at $3.58, up $0.53 or 17.16%
--Would be highest close since June 7, 2024, when it closed at $3.62
--On pace for largest percent increase since Aug. 10, 2022, when it rose 20.07%
--Currently up four of the past five days
--Currently up three consecutive days; up 21.94% over this period
--Best three day stretch since the three days ending Aug. 12, 2022, when it rose 23.13%
--Up 22.35% month-to-date
--Up 22.35% year-to-date
--Down 93.91% from its all-time closing high of $58.90 on Dec. 11, 2020
--Down 31.84% from 52 weeks ago (Jan. 24, 2024), when it closed at $5.26
--Down 35.87% from its 52-week closing high of $5.59 on Jan. 29, 2024
--Up 50% from its 52-week closing low of $2.39 on Sept. 6, 2024
--Traded as high as $3.68; highest intraday level since June 7, 2024, when it hit $3.76
--Up 20.26% at today's intraday high; largest intraday percent increase since Aug. 10, 2022, when it rose as much as 23.67%
All data as of 2:49:14 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 22, 2025 14:52 ET (19:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.